Crestline Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-127,820
Closed -$8.75M 241
2022
Q1
$8.75M Buy
127,820
+46,480
+57% +$3.31M 1.05% 12
2021
Q4
$6.43M Buy
+81,340
New +$6.8M 0.48% 42
2018
Q4
Sell
-37,113
Closed -$2.3M 112
2018
Q3
$2.3M Sell
37,113
-3,612
-9% -$206K 0.21% 85
2018
Q2
$2.15M Buy
40,725
+3,801
+10% +$205K 0.23% 129
2018
Q1
$2.03M Sell
36,924
-3,248
-8% -$200K 0.25% 61
2017
Q4
$2.74M Buy
+40,172
New +$2.7M 0.28% 31
2017
Q3
Sell
-26,105
Closed -$1.77M 138
2017
Q2
$1.77M Sell
26,105
-246
-0.9% -$16.8K 0.24% 48
2017
Q1
$1.78M Buy
26,351
+12,761
+94% +$851K 0.33% 35
2016
Q4
$840K Buy
+13,590
New +$803K 0.21% 32

Other funds holding ENOV

Crestline Management's ENOV Position: Q2 2022 in Review

Crestline Management sold out of Enovis (ENOV) in Q2 2022, closing a stake of 127,820 shares — an estimated $8.75M sold.

Crestline Management first reported a position in ENOV in Q4 2016 and held it in 9 quarters. The position peaked at $8.75M in Q1 2022. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

  • Crestline Management reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
  • Crestline Management sold 127,820 Enovis shares in Q2 2022, an estimated $8.75M.
  • Crestline Management first reported a position in Enovis in Q4 2016 and held it in 9 quarters.
  • Crestline Management's Enovis position peaked at $8.75M in Q1 2022.
  • 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on Crestline Management's 13F filing for Q2 2022, filed 12 Aug 2022.